Search

Search Constraints

You searched for: Author/Creator Martin, P

Search Results

2. 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial. Issue 10191 (29th June 2019)

3. 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial. Issue 10191 (29th June 2019)

7. Association between surgeon special interest and mortality after emergency laparotomy. Issue 7 (25th April 2019)

9. Basal characteristics of the prospective spanish immunotherapy registry of cardiovascular toxicity: SIR-CVT. (3rd October 2022)

10. CD69 expression in regulatory T cells protects from the immune-mediated damage after myocardial infarction. (14th October 2021)